
|Videos|June 9, 2017
Current Legislative Efforts in Addressing Rising Drug Costs
Christopher Topoleski, Director of Federal Legislative Affairs for ASHP, talks about the ongoing legislative actions aimed at addressing rising medication costs in the drug industry.
Advertisement
Christopher Topoleski, Director of Federal Legislative Affairs for ASHP, talks about the ongoing legislative actions aimed at addressing rising medication costs in the drug industry.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Polycystic Ovary Syndrome Undergoes Name Change: Polyendocrine Metabolic Ovarian Syndrome
2
Amid Mounting Pressure, FDA Commissioner Marty Makary Resigns
3
GLP-1 Receptor Agonists Linked to Improved Survival Outcomes in Breast Cancer
4
From Misdiagnosis to Advocacy: Addressing Bias and Equity in Heart Failure Management
5


































































































































